| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Sr. VP Clinical Dev. &CMO
2 companies
Rubin Paul D is a Sr. VP Clinical Dev. &CMO at XOMA Royalty Corp with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $13.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | BIOA Bioage Labs, Inc. | Chief Medical Officer | Sale+OE | 7,433 | $12.85 | $95,490.26 | -100% | +36.4% | - | |
| Dec 9, 2025 | BIOA Bioage Labs, Inc. | Chief Medical Officer | Sale+OE | 18,000 | $12.00 | $216,000.00 | -100% | +63.5% | - | |
| Dec 4, 2025 | BIOA Bioage Labs, Inc. | Chief Medical Officer | Sale+OE | 68,897 | $10.19 | $701,908.86 | -100% | +100.7% | - | |
| Mar 22, 2016 | XOMA Xoma Royalty Corp | Sr. VP Clinical Dev. &CMO | Sale+OE | 24,194 | $0.78 | $18,985.03 | -6.9% | - | - | |
| Jul 15, 2015 | XOMA Xoma Royalty Corp | Sr. VP Clinical Dev. &CMO | Sale+OE | 5,000 | $4.60 | $22,992.00 | -3.9% | - | - | |
| Jul 10, 2015 | XOMA Xoma Royalty Corp | Sr. VP Clinical Dev. &CMO | Sale+OE | 33,400 | $4.55 | $152,004.80 | -12.0% | - | - | |
| May 28, 2015 | XOMA Xoma Royalty Corp | Sr. VP Clinical Dev. &CMO | Sale+OE | 1,788 | $3.60 | $6,436.80 | -1.4% | - | - | |
| Mar 23, 2015 | XOMA Xoma Royalty Corp | Sr. VP Clinical Dev. &CMO | Sell | 32,742 | $3.94 | $128,879.06 | -21.5% | - | - |